Putting the “bio” in “biotherapeutics”/Checkpoints for biosimilars/Application of biosimilars

Publication date: Available online 13 October 2016 Source:New Horizons in Translational Medicine Author(s): Juan V. Esplugues, Bruno Flamion, Lluis Puig Sanz The number of biosimilar medicines on the market is steadily increasing, due, in part, to patent expiration of several top-selling biologic medicines. These three e-learning modules discuss the basic concepts behind biosimilar medicines and highlight key regulatory considerations when using biosimilar medicines in medical practice.

Source: New Horizons in Translational Medicine - October 13, 2016 Category: Research Source Type: research